Top Markets
#1 Black Phoenix Black Phoenix +354.53%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.15%
#4 Akedo Akedo +52.53%
#5 Acurast Acurast +33.26%
#6 BasedHype BasedHype +27.64%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.45%
#9 Avantis Avantis +18.91%
#10 HOME HOME +14.74%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
株式のランク #40876
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
株価
$0.0127
最終同期: 2026-08-12
時価総額
$66.48K
変化（1日）
-2.31%
変化（1年）
-67.44%
国
US
取引 Vincerx Pharma, Inc. (VINC)

カテゴリー

Healthcare
Vincerx Pharma, Inc.（VINC）の株価履歴
終値の最高値: $0.01 （2026-08-01）

終値の最安値: $195.93 （2020-05-01）
Vincerx Pharma, Inc. の株価履歴（2020 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 86.64%
2025 -99.71%
2024 -70.59%
2023 -10.91%
2022 -91.75%
2021 -41.58%
2020 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $524.97 32.59%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $863.52 33.55%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE